Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

NCT01227928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Ovarian

Interventions

DRUG: Pazopanib
DRUG: Placebo comparator

Sponsor

GlaxoSmithKline